English TOP

Create the Future to Overcome Cancer

News

2023/04/24: Alliance between Noile-Immune Biotech, Inc. and Rebirthel Co., Ltd. on PRIME allogeneic CAR-T Cell Therapy using Immune Cells induced from Pluripotent Stem Cells

2023/04/24: An interview with our president and CEO, Koji Tamada, was published in the International Pharmaceutical Intelligence Magazine (Dec. 26, 2022 published) under the title of "Top Interview: Creating New Therapeutic Options for Solid Cancer with PRIME CAR-T Cell Technologies." (the article is in Japanese)

2023/04/13: Publication of Research Papers on CAR-T Cells with Our Platform-based Technologies

2022/11/25: Interim results of Phase 1 clinical trial evaluating the ‘PRIME' CAR-T cell therapy TAK-102 (NIB102) expressing IL-7/CCL19 in patients with GPC3 positive solid tumors were presented at the 37th Annual Meeting of SITC

2022/09/12: On September 11, 2022, our president, Koji Tamada, appeared on NHK Science Zero, ”Challenge cancer with immune-therapy ! CAR-T Cell Therapy”